Meeting Development and Manufacturing Demands for Emerging Therapies

Register Free: https://www.pharmtech.com/pt_w/interphex3

Event Overview:

Cell therapies and gene therapies continue to challenge the development and manufacturing capabilities of biopharma companies and contract manufacturers. These therapies and personalized medicines, however, require analytical methods, supply chains, manufacturing processes, and regulatory standards that may be different from more traditional biologic drug development and manufacturing.

This Technology Forum will explore the current state of commercialization for cell and gene therapies and the patient and physician perspective, as well as the need for technologies, processes, and strategies to ensure competent delivery of these treatments to patients.

Among the challenges to be addressed are capacity scale up, material shortages, and temperature-dependent requirements as well as the variables (e.g., type of diseases, patient health conditions, strict time constraints, etc.) that drive turnaround times for cell and gene therapies, and, therefore, the need for innovative production, logistics, and delivery technologies.

Key Learning Objectives:

Topics discussed during this webcast include the following:

• Review current market and regulatory dynamics for cell and gene therapies.
• Understand the development and manufacturing challenges from the patient perspective.
• Learn about technologies and processes to facilitate development and manufacturing.
• Hear about efforts to reduce turnaround time, ensure a safe supply chain, and manage delivery to patients.

Who Should Attend:

• Small biotech companies developing cell therapies and gene therapies
• Development and manufacturing teams at mid-size and large bio/pharma companies
• Corporate and development experts
• Process development and manufacturing experts

Register Free: https://www.pharmtech.com/pt_w/interphex3